Lucid Diagnostics Inc. (LUCD) stock
LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3038% above fair value
$0.39−0.02 (-5.25%)
Close on Nov 19, 2026Market cap $78.51MP/E –Yield –
Lucid Diagnostics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Lucid Diagnostics's free cash flow for the twelve months ending Mar 31, 2023 was -$34.10M. For fiscal 2025 it was -$46.68M.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$46.68M | – |
| FY2024 | Dec 31, 2024 | -$44.44M | – |
| FY2022 | Dec 31, 2022 | -$32.89M | – |
| FY2021 | Dec 31, 2021 | -$18.53M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$11.32M | – |
| Q1 FY2026 | Mar 31, 2026 | -$12.32M | – |
| Q2 FY2025 | Jun 30, 2025 | -$10.57M | – |
| Q1 FY2025 | Mar 31, 2025 | -$12.56M | – |
| Q1 FY2023 | Mar 31, 2023 | -$7.14M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.26M | – |
| Q3 FY2022 | Sep 30, 2022 | -$7.35M | – |
| Q2 FY2022 | Jun 30, 2022 | -$15.36M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.92M | – |
| Q4 FY2021 | Dec 31, 2021 | -$10.70M | – |
| Q3 FY2021 | Sep 30, 2021 | -$2.21M | – |
| Q2 FY2021 | Jun 30, 2021 | -$2.30M | – |
| Q1 FY2021 | Mar 31, 2021 | -$3.32M | – |
See a number that looks wrong?